Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World January 21, 2011 Jennifer Newton	Early lung cancer diagnosis Patients with lung cancer have elevated levels of a specific protein in their blood that could be used as a biomarker for the disease, say scientists from South Korea.
Managed Care December 2007	Web Site Helps Track Health Plan Rankings U.S. News & World Report and the National Committee for Quality Assurance have released the third edition of America's Best Health Plans, an annual ranking of health maintenance organizations and point-of-service plans.
Managed Care July 2007 Lola Butcher	Consumer-Directed Plans Fall Short of Expectation As the consumer-directed health plan design approaches its seventh year in the marketplace, some wonder if it will ever be more than a niche product.
AskMen.com Harold Russell	The Truth About Lung Cancer Read this article to find out about the causes, symptoms, treatments, and preventive measures of lung cancer.
The Motley Fool June 15, 2010 Brian Orelli	Just Enough to Give Investors Hope Hitting a secondary endpoint means all is not lost for Onyx's lung cancer drug.
BusinessWeek May 23, 2005 Catherine Arnst	If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer.
The Motley Fool December 20, 2004 Charly Travers	More Trouble at Big Pharma AstraZeneca's lung cancer drug is not as effective as once hoped.
American Family Physician February 1, 2001 Thomas J. Gates	Screening for Cancer: Evaluating the Evidence This article reviews the kind of evidence required to justify screening tests for cancer, with the goal of guiding family physicians through current and future screening controversies...
The Motley Fool April 12, 2005 Brian Gorman	Genentech's Cancer Quest The company's achievements in lung cancer further strengthen its reputation as a cancer fighter. Would-be investors are best served by waiting patiently.
Managed Care February 2004 MargaretAnn Cross	Why Workers Choose CDHPs: Matter of Dollars and Sense In a new study of how consumer-directed plans are doing, one finding is that lower premiums was not a major factor in whether workers selected such a plan.
Managed Care January 2005	NCQA Hopes 10-Best Lists Spur Consumer Interest Medicaid Top 10: BlueCross BlueShield of Western New York... HealthPlus of Michigan... UPMC Health Plan... Medicare Top 10: Blue Cross and Blue Shield of Massachusetts... Capital Health Plan... HealthPartners... etc.
The Motley Fool April 26, 2004 Alyce Lomax	Genentech's Lucky Day Genentech and OSI Pharmaceuticals jump in today's trading session after favorable trial results for a cancer drug.
Managed Care June 2005 MargaretAnn Cross	Consumer-Directed and Home-Brewed Regional health plans and small HMOs coming late to the consumer-directed health plan market haven't missed out -- yet.
The Motley Fool March 30, 2010 Brian Orelli	Invest in This Space at Your Own Risk Lung cancer is a tough foe for drugmakers.
BusinessWeek February 16, 2004 Catherine Arnst	Medicare vs. Cancer Patients Refusing to reimburse off-label treatment is far from the best way to cut costs.
Managed Care November 2005 MargaretAnn Cross	Health Plans by Design, Not by Default Fortune 500 employers are ready to shed old benefit models for "managed consumerism".
Managed Care March 2008 Frank Diamond	What Makes Harvard Pilgrim So Good? It's the nation's leader in member satisfaction and quality of care, according to NCQA. Dynamic leadership and dominance of a region where excellent docs and plans abound are part of the formula.
Managed Care July 2005 John A. Marcille	Talk About Consumer Plans Rapidly Becoming Reality After years of expectation and debate, consumer-directed health plans are all over the place.
The Motley Fool April 27, 2011 Brian Orelli	Falling Into the Zaltrap Lung cancer out, colon cancer in phase 3 clinical trial for Regeneron Pharmaceuticals' new drug.
The Motley Fool June 17, 2010 Luke Timmerman	Oncothyreon's Cancer Vaccine Back in the Saddle as Merck KGaA Re-Starts Clinical Trials The German-based Merck got clearance from the FDA and local ethics review boards to resume two of three large pivotal trials.
Managed Care May 2005 MargaretAnn Cross	Are Consumers Really Directing Their Own Care? In theory, consumer-directed health plans put the reins of decision making into the hands of their members. But medical management departments are alive and well inside CDHPs -- and may even expand under these plan designs.
Managed Care September 2007	Headlines On Deadline ... The underinsured account for 24 percent of the United States population... Communicating with employees is the greatest challenge employers face when introducing a consumer-directed health plan... etc.
BusinessWeek June 21, 2004 Catherine Arnst	Cancer Superdrugs, Costly Side Effects New therapies are extending lives, but the prices could weigh down the nation. Oncologists, pharmaceutical companies, and the government will have to focus on the best way to lower prices for these drugs.
Managed Care March 2007 Martin Sipkoff	Managing Cancer Treatment Begins Before Diagnosis Health plans are increasingly involved in promoting the lifestyle changes that help their members avoid cancer, and are increasingly involved in clinical trials if prevention fails.
CFO February 1, 2008 Randy Myers	Rethinking Health Care Can more employee choice actually lower costs?
Managed Care November 2004 MargaretAnn Cross	Accrediting Agencies Turn Attention To Consumer-Directed Health Plans If employers make decisions based on United Regional Health Care Foundation's and National Committee for Quality Assurance's rating of traditional managed care plans, shouldn't they want similar ratings of consumer-directed health plans?
American Family Physician March 15, 2007 Mark H. Ebell	Point-of-Care Guides: Estimating 10-Year Mortality Risks Clinical Question: What is a patient's risk of dying from vascular disease, cancer, infection, an accident, or any cause within the next 10 years?... Evidence Summary... Applying the Evidence... etc.
AskMen.com	Good Health Care News New advice from the American Cancer Society puts a sharper focus on the risks of prostate cancer screening, emphasizing that annual testing can lead to unnecessary biopsies and treatments that do more harm than good.
Science News May 13, 2000	Cancer Net CancerNet is a huge compendium of information on cancer assembled by the National Cancer Institute....
Managed Care August 2005 MargaretAnn Cross	Consumers in This Market Struggle To Keep Their HMOs Rochester, N.Y., faces rising health care costs and a growing employer interest in consumer-directed health plans. Can a managed care town hold its own?
Managed Care June 2006	Survey: Workers Not Guided When Choosing Care A study shows employers believe their workers can learn what they need to know to become better buyers of health services.
Managed Care October 2005 MargaretAnn Cross	Just How Will CDHC Change Your Job? Medical directors are charged with many of the tasks that could help members make the most of consumer-directed health plans.
Managed Care June 2007 Lola Butcher	Big Companies Holding Fast To Employer-Sponsored System In board rooms across the country, decisions are being made to battle, rather than run from, rising costs of health care.
Managed Care August 2004	Computer Game Simulates Coverage and Outcomes Consumer-directed health care plans can work, say employers in a recent survey, if the right tactics are used to help workers manage their health and benefits better.
American Family Physician February 15, 2005	Health Care After Cancer Treatment An informative patient hand-out on follow-up cancer care.
Managed Care March 2007 Lola Butcher	Plans Put Greater Emphasis On Cancer Management Increasingly, health plans are rolling out services designed to help cancer patients and, before that, plan members at a high risk of cancer, to improve their health care and, in doing so, limit costs.
Managed Care June 2005 Frates & Severoni	Consumer-Directed Health Plans: Enrollee Views, Early Employer Experience As CDHPs increasingly penetrate the commercial market, their greatest contribution might lie in funding health services for retirees and in reducing the number of uninsured people by offering affordable insurance.
Managed Care September 2003 MargaretAnn Cross	Consumer-Directed Health Care: Too Good To Be True? People talk about it as the sure way to control costs and give consumers the choice they seem to want. Are we being realistic?
The Motley Fool October 27, 2006 Jack Uldrich	Nanotech and the War on Cancer New imaging advances in nanotechnology will help speed cancers' end. What does it mean for investors?
Managed Care November 2007 MargaretAnn Cross	The Evolving Health Plan The consumer-directed health care model isn't taking the country by storm, but its innovations are influencing other coverage designs.
The Motley Fool July 16, 2007 Brian Lawler	Slight Setback for ImClone ImClone announces a failed cancer study. Investors, take note.
Science News May 19, 2007	Science Safari: Cancer Risk -- Understanding the Puzzle This new Web site from the National Cancer Institute cuts through the hype to help you understand the plain and simple truth about cancer risk.
The Motley Fool March 30, 2011 Brian Orelli	Amgen's Long Shot Comes Up Short Amgen and Takeda Pharmaceutical's motesanib didn't extend overall survival in lung cancer patients when combined with Bristol-Myers Squibb's Taxol and carboplatin.
The Motley Fool September 28, 2010 Brian Orelli	Pfizer's Sutent Fails. Again! No surprise here.
Managed Care August 2007	Consumer-Directed Health Plans: Built to Last or Designed to Fail? A point-counterpoint debate about the effect of CDHPs on overall health and health care costs.
The Motley Fool June 6, 2011 Brian Orelli	Big Pharma Tackles Lung Cancer; Biotech Helping, Too A big underserved market.
American Family Physician January 1, 2007 Collins et al.	Lung Cancer: Diagnosis and Management Smoking cessation remains the critical component of preventive primary care of lung cancer. Treatment and prognosis are closely tied to the type and stage of the tumor identified.
BusinessWeek May 9, 2005 Catherine Arnst	Genentech's Lessons For Big Pharma The biotech company focuses on science -- not marketing, acquisitions, or patents.
The Motley Fool December 3, 2004 W.D. Crotty	One Hot Biotech Stock Biomira reports favorable Phase II test results, sending the stock up 146%.
The Motley Fool November 21, 2008 Brian Orelli	Coughing Is Bad for Amgen's Health Safety concerns halt drug trial, but all is not lost.